Eli Lilly (LLY) cuts revenue forecast
Eli Lilly and Co. reported lower-than-expected sales for its top-selling diabetes drug, Trulicity, and cut its full-year revenue forecast. Due to pressure to lower prices, Eli Lilly agreed to offer a half-priced version of insulin injection Humalog earlier this year. The drugmaker is one of the three main global providers of insulin products.
Lilly said it now expects 2019 revenue to come in between $22.0 billion and $22.5 billion, lower than its prior forecast of $25.1 billion to $25.6 billion. Analysts had expected $22.17 billion.
LLY's RSI Indicator sits in oversold zone for 1 day
It is expected that a price bounce should occur soon.
Show more
Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).
Industry description
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
Market Cap
The average market capitalization across the Pharmaceuticals: Major Industry is 86.34B. The market cap for tickers in the group ranges from 72.83K to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is CRXTQ at 72.83K.
High and low price notable news
The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 6%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was 5%. MIRA experienced the highest price growth at 287%, while JCRRF experienced the biggest fall at -18%.
Volume
The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 46%. For the same stocks of the Industry, the average monthly volume growth was 99% and the average quarterly volume growth was 65%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 34
P/E Growth Rating: 46
Price Growth Rating: 51
SMR Rating: 64
Profit Risk Rating: 69
Seasonality Score: -6 (-100 ... +100)